Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Phenotyping of Evi1, Evi11/Cb2, and Evi12 transformed leukemias isolated from a novel panel of cas-Br-M murine leukemia virus-infected mice.

Virology - 15 Mar 2000

Joosten M, Valk P J, Vankan Y, de Both N, Löwenberg B, Delwel R

Abstract excerpt

Cas-Br-M murine leukemia virus (MuLV) is a slow-transforming retrovirus that potently induces leukemias in mice and therefore is well suited for retroviral insertional mutagenesis. We used Cas-Br-M MuLV in NIH/Swiss mice to establish a new panel of mainly myeloid leukemias. All tumors found in leukemic animals were classified by gross pathology, morphology, and immunophenotype, as well as the incidence of known...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 3T3 Cells
Share to Cell Transformation, Viral

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Leukemia, Experimental

Share to Leukemia Virus, Murine

Share to Proto-Oncogenes

Share to Retroviridae Infections

Share to Tumor Virus Infections

Share to Virus Integration

Source

Identifiers

PMID: 10704339
DOI: 10.1006/viro.2000.0183

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Phenotyping of Evi1, Evi11/Cb2, and Evi12 transformed leukemias isolated from a novel panel of cas-Br-M murine leukemia virus-infected mice.PMID 10704339Read ↗

Pathogenetic significance of ecotropic viral integration site-1 in hematological malignancies.Semantic proximity Read ↗

Genetic heterogeneity in acute myeloid leukemia: maximizing information flow from MuLV mutagenesis studies.Semantic proximity Read ↗

Evi1 defines leukemia-initiating capacity and tyrosine kinase inhibitor resistance in chronic myeloid leukemia.Semantic proximity Read ↗

Erythroid defects and increased retrovirally-induced tumor formation in Evi1 transgenic mice.Semantic proximity Read ↗

EVI1 dysregulation: impact on biology and therapy of myeloid malignancies.Semantic proximity Read ↗

AML1-Evi-1 specifically transforms hematopoietic stem cells through fusion of the entire Evi-1 sequence to AML1.Semantic proximity Read ↗

Essential role of PR-domain protein MDS1-EVI1 in MLL-AF9 leukemia.Semantic proximity Read ↗

EVI1 induces myelodysplastic syndrome in miceSemantic proximity Read ↗

Phenotypes of murine leukemia virus-induced tumors: influence of 3' viral coding sequences.Semantic proximity Read ↗

<i>Evi9</i> Encodes a Novel Zinc Finger Protein That Physically Interacts with BCL6, a Known Human B-Cell Proto-Oncogene ProductSemantic proximity Read ↗

Endogenous retrovirus induces leukemia in a xenograft mouse model for primary myelofibrosisSemantic proximity Read ↗

The MDS1–EVI1 Gene Complex as a Retrovirus Integration Site: Impact on Behavior of Hematopoietic Cells and Implications for Gene TherapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.